Repare Therapeutics on Monday said its Chief Financial Officer, Steve Forte, has been named as the company's president and chief executive officer, effective April 11. He succeeds Lloyd Segal, who has ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...

Traws Pharma (TRAW) announced the retirement of Werner Cautreels, CEO, effective on or about close of business on March 31 after the company ...

Felix Baker will succeed Pierre Legault as chairman of the Bicycle Therapeutics (BCYC) board of directors as Legault and Richard Kender, will ...

A Waltham company pulled the plug on a Phase 3 cancer trial, while a different Waltham company continued its leadership ...

Multinational pharmaceutical firms, particularly U.S. giants, are increasingly recognizing China's burgeoning innovative drug sector as a strategic goldmine to bolster their global competitiveness.

Prosecutors do not want Luigi Mangione, the suspect in the murder of UnitedHealthcare CEO Brian Thompson, to have a laptop in ...

Someone tucked a heart-shaped note of encouragement into a pair of socks packed for Luigi Mangione to wear to a court ...

Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round Novo Holdings and Jeito Capital co-led the deal, supported by Asabys Partners and existing investo ...

It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...